Lungpacer Medical has began subject enrolment in Phase II STimulation to Activate RespIration (STARI) trial, assessing the ...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

Lungpacer Medical announced today that it enrolled the first six patients in its STARI clinical trial for its next-generation ...

The former wife of DOC Commissioner Paul Schnell has been sentenced to three years in prison for trying to kill their ...

Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced the first six patients enrolled in the groundbreaking STARI (STimulation ...

Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced the first six patients enrolled in the groundbreaking STARI (STimulation ...

CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...

Jayden Wilsey was the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease after federal approval in 2024.

The latest edition of La Marató de 3Cat raised 10 million euros, which will fund 36 research projects on respiratory diseases ...

Enters agreements for a $12 million promissory note and a $20 million equity line of credit with Streeterville Capital Proforma cash, cash equivalents, restricted cash and marketable securities of $22 ...

Research and development expenses for the fiscal quarter ended September 30, 2025 were $2.5 million compared with $4.6 million for the fiscal quarter ended September 30, 2024. The decrease of $2.1 ...